Senti Biosciences, Inc.SNTINASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank60
3Y CAGR-4.8%
5Y CAGR+55.6%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
-4.8%/yr
Annual compound
5Y CAGR
+55.6%/yr
Recent deceleration
Percentile
P60
Within normal range
vs 5Y Ago
9.1x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2024$48.28M+34.4%
2023$35.93M-37.7%
2022$57.62M+2.8%
2021$56.03M+83.5%
2020$30.54M+476.1%
2019$5.30M-